| Serial Number | 79143473 |
| Word Mark | THERAMETRICS |
| Filing Date | Friday, November 22, 2013 |
| Status | 404 - IR CANCELLED - US REGISTRATION CANCELLED |
| Status Date | Tuesday, November 21, 2023 |
| Registration Number | 4654777 |
| Registration Date | Tuesday, December 16, 2014 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 30, 2014 |
| Goods and Services | Pharmaceutical preparations for the treatment of cardiovascular and respiratory diseases, pulmonary fibrosis, sarcoidosis, lung disease, viral diseases, and infectious diseases; chemical preparations for sanitary purposes for medicine; pharmaceutical products for the treatment of idiopathic pulmonary arterial hypertension, familial pulmonary arterial hypertension, scleroderma, lupus erythematosus associated pulmonary hypertension, congenital systemic-to-pulmonary shunts associated pulmonary hypertension, portal hypertension associated pulmonary hypertension, HIV infection associated pulmonary hypertension, drugs and toxins associated pulmonary hypertension, glycogen storage disease associated pulmonary hypertension, Gaucher disease associated pulmonary hypertension, hereditary hemorrhagic telangiectasia associated pulmonary hypertension, hemoglobinopathies associated pulmonary hypertension, myeloproliferative disorders associated pulmonary hypertension, pulmonary veno-occlusive disease associated pulmonary hypertension, pulmonary capillary hemangiomatosis associated pulmonary hypertension, persistent pulmonary hypertension of the newborn, left-sided atrial or ventricular heart disease associated pulmonary hypertension, left-sided valvular heart disease associated pulmonary hypertension, pulmonary hypertension associated with chronic obstructive pulmonary disease, pulmonary hypertension associated with interstitial lung diseases, pulmonary hypertension associated with sleep disordered-breathing, pulmonary hypertension associated with alveolar hypoventilation disorders, pulmonary hypertension associated with chronic exposure to high altitude, pulmonary hypertension associated with developmental abnormalities, pulmonary hypertension due to chronic thrombotic and embolic diseases, pulmonary embolism due to tumor, parasites, foreign material, pulmonary hypertension associated with in situ thrombosis, pulmonary hypertension associated with sarcoidosis, pulmonary hypertension associated with histiocytosis X, pulmonary hypertension associated with lymphangiomatosis, pulmonary hypertension associated with sickle-cell disease, Eisenmenger syndrome, chronic fatigue syndrome, bronchial asthma, rheumatoid arthritis, lupus, Goodpasture's syndrome, Wegener's granulomatosis, type 1 diabetes mellitus, Hashimoto's thyroiditis, Grave's disease, multiple sclerosis, Guillain-Barre syndrome, Addison's disease, acute disseminated encephalomyelitis, antiphospholipid antibody syndrome, aplastic anemia, myasthenia gravis, opsoclonus myoclonus syndrome, optic neuritis, Ord's thyroiditis, acute respiratory distress syndrome, acute lung injury, Hamman-Rich syndrome, idiopathic pulmonary fibrosis, bronchiolitis obliterans, hypersensitivity pneumonitis, lymphangiomyomatosis (LAM), usual interstitial pneumonia (UIP), Von Gierke syndrome, Osler-Weber-Rendu-Syndrome, small cell lung carcinoma, cystic fibrosis, tuberculosis, Hepatitis B virus infections, psoriasis, allergic dermatitis, scar keloids, pyogenic granulomas, blistering disease, Kaposi sarcoma in AIDS patients, systemic sclerosis, persistent hyperplastic vitreous syndrome, diabetic retinopathy, retinopathy of prematurity, choroidal neovascularization, inflammatory bowel disease, periodontal disease, ascites, peritoneal adhesions, endometriosis, uterine bleeding, ovarian cysts, ovarian hyperstimulation, osteomyelitis, osteophyte formation, HIV-induced bone marrow angiogenesis, early diabetic nephropathy, cancer and malignancies and their metastases in numerous organs, hemangiomas, vasculitis, Sjögren's disease, DiGeorge syndrome, hereditary haemorrhagic telangiectasia, cavernous hemangioma, cutaneous hemangioma, lymphatic malformations, transplant arteriopathy, vascular anastomoses, adipose tissue in obesity, chronic allograft rejections; chemical preparations intended for healing, health care or medical and veterinary purposes, namely, chemical preparations for treating inflammatory, cardiovascular and respiratory diseases, pulmonary fibrosis, sarcoidosis, lung disease, viral diseases, and infectious diseases; chemical reagents for medical or veterinary purposes; diagnostic preparations for medical purposes; radiological contrast substances for medical purposes; detergents for medical purposes; medicated mouth care and treatment preparations; medicated skin care preparations |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Scientific research to order; conducting of research and development in the medical, pharmaceutical, pharmacological, biochemical and/or medical technology fields for others; conducting to order clinical studies and tests, namely, conducting clinical trials for others; assessment to order of scientific projects, namely, conducting scientific feasibility studies; scientific research consulting in the nature of evaluation to order of clinical studies and experiments; providing technical advice relating to operation of computers; providing scientific cooperations in the nature of providing scientific information in the field of pharmaceutical research; conducting scientific research projects in the medical, pharmaceutical, pharmacological, biochemical, and/or medical technology fields for others; scientific analysis laboratories |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, July 2, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Friday, July 2, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | THERAMetrics holding AG |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | CH |
| Party Name | THERAMetrics holding AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | CH |
| Party Name | THERAMetrics holding AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | CH |
| Event Date | Event Description |
| Friday, March 7, 2014 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, March 10, 2014 | ASSIGNED TO EXAMINER |
| Friday, March 14, 2014 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, March 14, 2014 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, April 4, 2014 | REFUSAL PROCESSED BY IB |
| Thursday, March 6, 2014 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Tuesday, March 11, 2014 | APPLICATION FILING RECEIPT MAILED |
| Thursday, March 13, 2014 | NON-FINAL ACTION WRITTEN |
| Friday, March 14, 2014 | REFUSAL PROCESSED BY MPU |
| Friday, May 23, 2014 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, June 5, 2014 | ASSIGNED TO LIE |
| Thursday, July 3, 2014 | FINAL REFUSAL WRITTEN |
| Thursday, July 3, 2014 | FINAL REFUSAL E-MAILED |
| Thursday, July 3, 2014 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Wednesday, August 20, 2014 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Wednesday, August 20, 2014 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, August 21, 2014 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, August 22, 2014 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, June 10, 2014 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, June 10, 2014 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, September 10, 2014 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 30, 2014 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 16, 2014 | REGISTERED-PRINCIPAL REGISTER |
| Thursday, May 7, 2015 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, June 12, 2015 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Wednesday, August 27, 2014 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Tuesday, September 30, 2014 | PUBLISHED FOR OPPOSITION |
| Monday, March 16, 2015 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Thursday, May 7, 2015 | FINAL DISPOSITION PROCESSED |
| Monday, December 16, 2019 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| Thursday, July 7, 2022 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| Monday, February 10, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, July 2, 2021 | CANCELLED SECTION 71 |
| Wednesday, March 2, 2022 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
| Thursday, July 7, 2022 | INVALIDATION PROCESSED |
| Sunday, June 16, 2024 | DEATH OF INTERNATIONAL REGISTRATION |
| Sunday, June 16, 2024 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED |
| Monday, August 8, 2022 | TOTAL INVALIDATION PROCESSED BY THE IB |